Literature DB >> 34249452

Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognostic factors.

Hiroki Matsukawa1, Noriho Iida1, Kazuya Kitamura1, Takeshi Terashima1, Jun Seishima1, Isamu Makino2, Takayuki Kannon3, Kazuyoshi Hosomichi3, Taro Yamashita1, Yoshio Sakai1, Masao Honda4, Tatsuya Yamashita1, Eishiro Mizukoshi1, Shuichi Kaneko1.   

Abstract

Microbiota in the gut and oral cavities of pancreatic cancer (PC) patients differ from those of healthy persons, and bacteria in PC tissues are associated with patients' prognoses. However, the species-level relationship between a dysbiotic gut, oral and cancerous microbiota, and prognostic factors remains unknown. Whole-genome sequencing was performed with fecal DNA from 24 PC patients and 18 healthy persons (HD). Microbial taxonomies, metabolic pathways, and viral presence were determined. DNA was sequenced from saliva and PC tissues, and the association between the gut, oral, and cancer microbiota and prognostic factors in PC patients was analyzed. The PC microbiota were altered from those of the healthy microbiota in terms of microbial taxonomy, pathways and viral presence. Twenty-six species differed significantly between the PC and HD microbiota. Six fecal microbes, including Klebsiella pneumoniae, were associated with an increased hazard of death. In the co-occurrence network, microbes that were abundant in PC patients were plotted close together and formed clusters with prognosis-associated microbes, including K. pneumoniae. Multiple salivary microbes were present in the co-occurrence network. Microbacterium and Stenotrophomonas were detected in the PC tissues and formed a network with the fecal and salivary microbes. The dysbiotic gut microbiota in the PC patients formed a complex network with the oral and cancerous microbiota, and gut microbes abundant in the PC patients were closely linked with poor prognostic factors in the network. AJCR
Copyright © 2021.

Entities:  

Keywords:  Metagenome; ductal adenocarcinoma; microbiome; prognosis; virome

Year:  2021        PMID: 34249452      PMCID: PMC8263681     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  34 in total

1.  Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks.

Authors:  Jing Gao; V Glenn Tarcea; Alla Karnovsky; Barbara R Mirel; Terry E Weymouth; Christopher W Beecher; James D Cavalcoli; Brian D Athey; Gilbert S Omenn; Charles F Burant; H V Jagadish
Journal:  Bioinformatics       Date:  2010-02-07       Impact factor: 6.937

2.  Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.

Authors:  Nobuhiro Nakamoto; Nobuo Sasaki; Ryo Aoki; Kentaro Miyamoto; Wataru Suda; Toshiaki Teratani; Takahiro Suzuki; Yuzo Koda; Po-Sung Chu; Nobuhito Taniki; Akihiro Yamaguchi; Mitsuhiro Kanamori; Nobuhiko Kamada; Masahira Hattori; Hiroshi Ashida; Michiie Sakamoto; Koji Atarashi; Seiko Narushima; Akihiko Yoshimura; Kenya Honda; Toshiro Sato; Takanori Kanai
Journal:  Nat Microbiol       Date:  2019-01-14       Impact factor: 17.745

3.  Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4.

Authors:  Madhukumar Venkatesh; Subhajit Mukherjee; Hongwei Wang; Hao Li; Katherine Sun; Alexandre P Benechet; Zhijuan Qiu; Leigh Maher; Matthew R Redinbo; Robert S Phillips; James C Fleet; Sandhya Kortagere; Paromita Mukherjee; Alessio Fasano; Jessica Le Ven; Jeremy K Nicholson; Marc E Dumas; Kamal M Khanna; Sridhar Mani
Journal:  Immunity       Date:  2014-07-24       Impact factor: 31.745

4.  Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

Authors:  Leore T Geller; Michal Barzily-Rokni; Tal Danino; Oliver H Jonas; Noam Shental; Deborah Nejman; Nancy Gavert; Yaara Zwang; Zachary A Cooper; Kevin Shee; Christoph A Thaiss; Alexandre Reuben; Jonathan Livny; Roi Avraham; Dennie T Frederick; Matteo Ligorio; Kelly Chatman; Stephen E Johnston; Carrie M Mosher; Alexander Brandis; Garold Fuks; Candice Gurbatri; Vancheswaran Gopalakrishnan; Michael Kim; Mark W Hurd; Matthew Katz; Jason Fleming; Anirban Maitra; David A Smith; Matt Skalak; Jeffrey Bu; Monia Michaud; Sunia A Trauger; Iris Barshack; Talia Golan; Judith Sandbank; Keith T Flaherty; Anna Mandinova; Wendy S Garrett; Sarah P Thayer; Cristina R Ferrone; Curtis Huttenhower; Sangeeta N Bhatia; Dirk Gevers; Jennifer A Wargo; Todd R Golub; Ravid Straussman
Journal:  Science       Date:  2017-09-15       Impact factor: 47.728

5.  Fecal microbiome signatures of pancreatic cancer patients.

Authors:  Elizabeth Half; Nirit Keren; Leah Reshef; Tatiana Dorfman; Ishai Lachter; Yoram Kluger; Naama Reshef; Hilla Knobler; Yaakov Maor; Assaf Stein; Fred M Konikoff; Uri Gophna
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

6.  Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.

Authors:  Daniel E Freedberg; Nora C Toussaint; Sway P Chen; Adam J Ratner; Susan Whittier; Timothy C Wang; Harris H Wang; Julian A Abrams
Journal:  Gastroenterology       Date:  2015-07-09       Impact factor: 22.682

7.  EBM-based Clinical Guidelines for Pancreatic Cancer (2013) issued by the Japan Pancreas Society: a synopsis.

Authors:  Koji Yamaguchi; Takuji Okusaka; Kyoko Shimizu; Junji Furuse; Yoshinori Ito; Keiji Hanada; Tooru Shimosegawa
Journal:  Jpn J Clin Oncol       Date:  2014-09-08       Impact factor: 3.019

Review 8.  Microbiota in pancreatic health and disease: the next frontier in microbiome research.

Authors:  Ryan M Thomas; Christian Jobin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-06       Impact factor: 46.802

9.  Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models.

Authors:  Ryan M Thomas; Raad Z Gharaibeh; Josee Gauthier; Mark Beveridge; Jillian L Pope; Maria V Guijarro; Qin Yu; Zhen He; Christina Ohland; Rachel Newsome; Jose Trevino; Steven J Hughes; Mary Reinhard; Kathryn Winglee; Anthony A Fodor; Maria Zajac-Kaye; Christian Jobin
Journal:  Carcinogenesis       Date:  2018-07-30       Impact factor: 4.944

10.  Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma.

Authors:  Noriho Iida; Eishiro Mizukoshi; Tatsuya Yamashita; Takeshi Terashima; Kuniaki Arai; Jun Seishima; Shuichi Kaneko
Journal:  Int J Cancer       Date:  2019-05-10       Impact factor: 7.396

View more
  5 in total

1.  Editorial: The Microbiome in Hepatobiliary and Intestinal Disease.

Authors:  Phillipp Hartmann
Journal:  Front Physiol       Date:  2022-04-13       Impact factor: 4.755

Review 2.  Recent Advances in Understanding the Structure and Function of the Human Microbiome.

Authors:  Walaa K Mousa; Fadia Chehadeh; Shannon Husband
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

3.  Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion.

Authors:  Ningning Zhang; Zeyu Wang; Jiayu Lv; Shuwen Zhang; Yang Liu; Tian Liu; Wang Li; Lan Gong; Xiaodong Zhang; Emad M El-Omar; Wei Lu
Journal:  Front Med (Lausanne)       Date:  2022-03-17

4.  A Commentary on the Potential Use of Oral Microbiome in Prediction, Diagnosis or Prognostics of a Distant Pathology.

Authors:  Egija Zaura
Journal:  Dent J (Basel)       Date:  2022-08-24

Review 5.  Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.

Authors:  Bartosz Kamil Sobocki; Karolina Kaźmierczak-Siedlecka; Marcin Folwarski; Viktoria Hawryłkowicz; Wojciech Makarewicz; Ewa Stachowska
Journal:  Nutrients       Date:  2021-12-10       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.